Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Vitamins a and B3: a new shield against skin cancer for transplant patients?

NCT ID NCT05702398

Summary

This early-stage study is testing whether daily vitamin A and vitamin B3 (nicotinamide) supplements are safe and can change blood nutrient levels in kidney transplant patients who have a high risk of skin cancer. The goal is to gather initial data to see if these vitamins could be used in future studies aimed at preventing skin cancer in this vulnerable group. The study will enroll 30 participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rhode Island Hospital

    RECRUITING

    Providence, Rhode Island, 02912, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.